TY - JOUR
T1 - Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia
T2 - Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study
AU - Wolfgruber, Stella
AU - Garcia-Vidal, Carolina
AU - Sedik, Sarah
AU - Salmanton-García, Jon
AU - Arikan-Akdagli, Sevtap
AU - Gangneux, Jean-Pierre
AU - Rautemaa-Richardson, Riina
AU - Arsić-Arsenijević, Valentina
AU - Martín-Pérez, Sonia
AU - Dávila-Valls, Julio
AU - Erben, Nurettin
AU - Akalin, Emin Halis
AU - Drgona, Lubos
AU - Lass-Flörl, Cornelia
AU - García-Rodríguez, Julio
AU - Bicanic, Tihana
AU - Hammarström, Helena
AU - Hamal, Petr
AU - Steinmann, J. rg
AU - Meijer, Eelco F. J.
AU - Khanna, Nina
AU - Desoubeaux, Guillaume
AU - Longval, Thomas
AU - Sili, Uluhan
AU - Trauth, Janina
AU - Bassetti, Matteo
AU - White, P. Lewis
AU - Aujayeb, Avinash
AU - Matos, Tadeja
AU - Akyol, Deniz
AU - Danion, Francois
AU - Lagrou, Katrien
AU - Rogers, Benedict
AU - Ruiz, Maite
AU - Siváková, Alena
AU - Mikulska, Malgorzata
AU - Samarkos, Michael
AU - Blennow, Ola
AU - Lockhart, Deborah E. A.
AU - Denis, Blandine
AU - Willinger, Birgit
AU - van Dijk, Karin
AU - Scharmann, Ulrike
AU - Goodman, Anna L.
AU - van Praet, Jens
AU - Narayanan, Manjusha
AU - Toscano, Cristina
AU - Loughlin, Laura
AU - de Jonge, Nick Alexander
AU - Ruiz-Gaitan, Alba
AU - Lanternier, Fanny
AU - Prattes, Juergen
AU - Roilides, Emmanuel
AU - Talento, Alida Fe
AU - Barac, Aleksandra
AU - Egger, Matthias
AU - Arendrup, Maiken Cavling
AU - Koehler, Philipp
AU - Cornely, Oliver A.
AU - Hoenigl, Martin
N1 - Publisher Copyright:
© The Author(s) 2026. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2026/4/1
Y1 - 2026/4/1
N2 - The European Confederation of Medical Mycology Candida III was a pan-European, multicenter observational study of adult patients with blood culture–proven candidemia. Among a total of 632 patients with candidemia across 64 institutions in 20 European countries, a subanalysis of 396 (63%) cases occurring outside the intensive care unit (ICU) was conducted. Compared with ICU patients, non-ICU patients had a higher comorbidity burden (median Charlson comorbidity index [CCI] 6 vs 5 in ICU patients, P = .006). Hematologic and oncologic malignancies were more frequent among non-ICU cases (45.5% vs 28.4%, P < .001), whereas both chronic kidney and cardiovascular disease were more prevalent in ICU patients (P < .001). Non-ICU patients had significantly lower mortality in Kaplan–Meier survival analysis (P > .001). Postsurgical non-ICU patients (n = 45) had the highest survival rate (73.3%, P = .003) and the longest hospital stay, even after excluding all cases with a fatal outcome before day 30. In non-ICU patients, older age, hemato-oncologic malignancies, chronic liver disease, and COVID-19 were all independently associated with mortality risk, while treatment consultation by an infectious disease or clinical microbiology consultant, and initial treatment with an echinocandin, respectively, higher EQUAL Candida scores were associated with lower mortality risk in the multivariable Cox regression models. In conclusion, despite higher comorbidity rates, non-ICU patients with candidemia had higher survival rates.
AB - The European Confederation of Medical Mycology Candida III was a pan-European, multicenter observational study of adult patients with blood culture–proven candidemia. Among a total of 632 patients with candidemia across 64 institutions in 20 European countries, a subanalysis of 396 (63%) cases occurring outside the intensive care unit (ICU) was conducted. Compared with ICU patients, non-ICU patients had a higher comorbidity burden (median Charlson comorbidity index [CCI] 6 vs 5 in ICU patients, P = .006). Hematologic and oncologic malignancies were more frequent among non-ICU cases (45.5% vs 28.4%, P < .001), whereas both chronic kidney and cardiovascular disease were more prevalent in ICU patients (P < .001). Non-ICU patients had significantly lower mortality in Kaplan–Meier survival analysis (P > .001). Postsurgical non-ICU patients (n = 45) had the highest survival rate (73.3%, P = .003) and the longest hospital stay, even after excluding all cases with a fatal outcome before day 30. In non-ICU patients, older age, hemato-oncologic malignancies, chronic liver disease, and COVID-19 were all independently associated with mortality risk, while treatment consultation by an infectious disease or clinical microbiology consultant, and initial treatment with an echinocandin, respectively, higher EQUAL Candida scores were associated with lower mortality risk in the multivariable Cox regression models. In conclusion, despite higher comorbidity rates, non-ICU patients with candidemia had higher survival rates.
KW - candidemia
KW - disease outcome
KW - invasive fungal infections
KW - non-ICU
UR - https://www.scopus.com/pages/publications/105040660836
U2 - 10.1093/ofid/ofag133
DO - 10.1093/ofid/ofag133
M3 - Article
C2 - 41918958
SN - 2328-8957
VL - 13
JO - Open Forum Infect. Dis.
JF - Open Forum Infect. Dis.
IS - 4
ER -